A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf Countries

NCT05214326 · clinicaltrials.gov ↗
COMPLETED
Status
187
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Sanofi